SCHEMBL10071039

SCHEMBL10071039

CCCCOc1cc(C2(O)CC(C)(C)CC(C)(C)C2)c(-c2ccccc2)c2cc3c(cc12)OC(OC)O3

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
RXRA P19793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041201 0.83
SCHEMBL15492815 0.82 BCHE (0.30) BCHEACHE
SCHEMBL10136492 0.82 RXRA (0.32) BCHEACHERXRA
SCHEMBL10070993 0.80 CYP1A2 (0.43) BCHEACHE
SCHEMBL15452289 0.79 THRA (0.32) RXRA
SCHEMBL13556886 0.79 DRD2 (0.31) RXRA
SCHEMBL10070138 0.78 BCHE (0.36) BCHEACHE
SCHEMBL10070479 0.78 PTPN11 (0.40)
SCHEMBL10070478 0.74 CDK5 (0.33) BCHEACHE
SCHEMBL10292876 0.73 PTPN1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120161089-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161089-A1 CHROMENE COMPOUND CYP8B1, HSD3B2, CYP17A1 BCHE 3562/4885ACHE 1371/4885RXRA 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.